Mo; Yun
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mo; Yun.The latest application filed is for "stable formulations of linaclotide".
Company Profile
11.14.41
- Mo; Yun - Foster City CA
- Mo; Yun - Commack NY
- Mo; Yun - Great Neck NY
- Mo; Yun - Miyagi JP
- Mo; Yun - Kurokawa-gun JP
- Mo; Yun - Dix Hills NY
- Mo; Yun - Cammack NY
- Mo; Yun - Tsukuba-shi JP
- Mo; Yun - Shenzhen CN
- Mo; Yun - Nirasaki JP
- Mo, Yun - Nirasaki-shi JP
Patent Activity
| Patent | Date |
|---|---|
| Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 11,452,723 - Li , et al. September 27, 2 | 2022-09-27 |
| Stable Formulations of Linaclotide App 20220233635 - Mo; Yun ; et al. | 2022-07-28 |
| Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20220125734 - Fretzen; Angelika ; et al. | 2022-04-28 |
| Low-Dose Stable Formulations of Linaclotide App 20220031802 - Mo; Yun ; et al. | 2022-02-03 |
| Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20210290554 - Fretzen; Angelika ; et al. | 2021-09-23 |
| Vacuum processing apparatus Grant 11,075,062 - Mo , et al. July 27, 2 | 2021-07-27 |
| Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20210161884 - Li; Shaoling ; et al. | 2021-06-03 |
| Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 10,946,009 - Li , et al. March 16, 2 | 2021-03-16 |
| Temperature Adjusting Device App 20210028029 - Mo; Yun | 2021-01-28 |
| Linaclotide Compositions App 20200222541 - Sanghvi; Ritesh ; et al. | 2020-07-16 |
| Stable formulations of linaclotide Grant 10,702,576 - Mo , et al. | 2020-07-07 |
| Stable formulations of linaclotide Grant 10,675,325 - Mo , et al. | 2020-06-09 |
| Vacuum Processing Apparatus App 20200161105 - Mo; Yun ; et al. | 2020-05-21 |
| Low-Dose Stable Formulations of Linaclotide App 20200038476 - Mo; Yun ; et al. | 2020-02-06 |
| Stable Formulations of Linaclotide App 20200030407 - MO; YUN ; et al. | 2020-01-30 |
| Stable Formulations of Linaclotide App 20200009216 - Mo; Yun ; et al. | 2020-01-09 |
| Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20190321350 - Li; Shaoling ; et al. | 2019-10-24 |
| Combination dosage form of a mu opioid receptor antagonist and an opioid agent Grant 10,369,142 - Li , et al. | 2019-08-06 |
| Stable Formulations of Linaclotide App 20190209644 - Mo; Yun ; et al. | 2019-07-11 |
| Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20190029967 - Fretzen; Angelika ; et al. | 2019-01-31 |
| Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20180050028 - Li; Shaoling ; et al. | 2018-02-22 |
| Low-Dose Stable Formulations of Linaclotide App 20180015139 - Mo; Yun ; et al. | 2018-01-18 |
| Linaclotide Compositions App 20170281774 - Sanghvi; Ritesh ; et al. | 2017-10-05 |
| Low-Dose Stable Formulations of Linaclotide App 20170157200 - Mo; Yun ; et al. | 2017-06-08 |
| Linaclotide Compositions App 20160324968 - Sanghvi; Ritesh ; et al. | 2016-11-10 |
| Delayed Release Compositions of Linaclotide App 20160310559 - Fretzen; Angelika ; et al. | 2016-10-27 |
| Low-Dose Stable Formulations of Linaclotide App 20160310560 - MO; Yun ; et al. | 2016-10-27 |
| Combination Dosage Form Of A Mu Opioid Receptor Antagonist And An Opioid Agent App 20160287573 - Li; Shaoling ; et al. | 2016-10-06 |
| Linaclotide compositions Grant 9,283,261 - Sanghvi , et al. March 15, 2 | 2016-03-15 |
| Stable Glucokinase Activator Compositions App 20160015638 - Mo; Yun ; et al. | 2016-01-21 |
| Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20150132375 - Fretzen; Angelika ; et al. | 2015-05-14 |
| Orally Disintegrating Compositions of Linaclotide App 20150031632 - MO; YUN ; et al. | 2015-01-29 |
| Linaclotide Compositions App 20150005241 - Sanghvi; Ritesh ; et al. | 2015-01-01 |
| Stable Formulations of Linaclotide App 20140378393 - Mo; Yun ; et al. | 2014-12-25 |
| Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20140287034 - Fretzen; Angelika ; et al. | 2014-09-25 |
| Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration Grant 8,802,628 - Fretzen , et al. August 12, 2 | 2014-08-12 |
| Formulations comprising linaclotide Grant 8,748,573 - Fretzen , et al. June 10, 2 | 2014-06-10 |
| Milnacipran Formulations App 20140023710 - Dedhiya; Mahendra G. ; et al. | 2014-01-23 |
| Linaclotide Compositions App 20140018307 - Sanghvi; Ritesh ; et al. | 2014-01-16 |
| Treatments Of Gastrointestinal Disorders App 20140005128 - Mo; Yun ; et al. | 2014-01-02 |
| Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20130273169 - Fretzen; Angelika ; et al. | 2013-10-17 |
| Substrate Cooling Device, Substrate Cooling Method And Heat Treatment Apparatus App 20130062035 - Kawakami; Masato ; et al. | 2013-03-14 |
| Orally Disintegrating Compositions of Linaclotide App 20130012454 - Mo; Yun ; et al. | 2013-01-10 |
| Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20120213846 - Fretzen; Angelika ; et al. | 2012-08-23 |
| Formulations Comprising Linaclotide App 20110059903 - Fretzen; Angelika ; et al. | 2011-03-10 |
| Milnacipran Formulations App 20100286260 - Dedhiya; Mahendra G. ; et al. | 2010-11-11 |
| Stable Solid Formulation of A GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20100048489 - Fretzen; Angelika ; et al. | 2010-02-25 |
| Handset Grant D586,772 - Su , et al. February 17, 2 | 2009-02-17 |
| Handset Grant D580,901 - Su , et al. November 18, 2 | 2008-11-18 |
| Thermal processing apparatus Grant 6,630,991 - Kitamura , et al. October 7, 2 | 2003-10-07 |
| Thermal processing apparatus App 20020020696 - Kitamura, Masayuki ; et al. | 2002-02-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 